CALTON & ASSOCIATES, INC. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$51,000
+24.4%
12,500
+8.7%
0.02%
+36.4%
Q4 2021$41,000
-47.4%
11,500
-46.5%
0.01%
-35.3%
Q3 2021$78,000
-17.0%
21,5000.0%0.02%
-5.6%
Q2 2021$94,000
+6.8%
21,5000.0%0.02%
+5.9%
Q1 2021$88,000
+2.3%
21,5000.0%0.02%
+13.3%
Q4 2020$86,000
+56.4%
21,500
+4.9%
0.02%
+36.4%
Q3 2020$55,000
-1.8%
20,5000.0%0.01%
-8.3%
Q2 2020$56,000
+16.7%
20,5000.0%0.01%0.0%
Q1 2020$48,000
-41.5%
20,500
+17.1%
0.01%
-25.0%
Q4 2019$82,000
+1071.4%
17,500
+400.0%
0.02%
+700.0%
Q4 2017$7,0003,5000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,055,0004.58%
Centric Wealth Management 3,337,449$13,717,0003.92%
Sargent Investment Group, LLC 3,599,580$14,794,0003.90%
Rubric Capital Management LP 8,722,647$35,850,0002.09%
PERKINS CAPITAL MANAGEMENT INC 542,283$2,229,0001.29%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$7,809,0001.17%
Venator Capital Management Ltd. 550,000$2,624,0000.89%
LEVEL FOUR FINANCIAL, LLC 120,000$493,0000.23%
ALGERT GLOBAL LLC 147,616$607,0000.19%
Brown Advisory Securities, LLC 275,000$1,130,0000.19%
View complete list of ANTARES PHARMA INC shareholders